Navigation Links
The 3 percent solution: Unpopular drug companies still push discovery

Madison, Wis. - John McNeish gives it a light-hearted spin when he talks about drug companies being one of the least trusted institutions in America.

"The polls say only 3 percent of the people in the country have a favorable view of drug companies," Pfizer executive McNeish told a group of about 75 people, mostly scientists, who gathered at Universit......

Full article >>> al for drug discovery," McNeish said.

While Pfizer has worked with mouse stem cells, it has not conducted experiments involving human stem cells. While McNeish and his colleagues see tremendous potential in working with such cells, they also see many financial and public policy risks.

The costs of bringing a drug to market are enormous, not counting the ads. Pfizer may unveil a c......

Full article >>> ncil and the Wisconsin Innovation Network. He is the former associate editor of the Wisconsin State Journal in Madison.

The opinions expressed herein or statements made in the above column are solely those of the author, and do not necessarily reflect the views of Wisconsin Technology Network, LLC. (WTN). WTN, LLC accepts no legal liability or responsibility for any claims made or op......

Full article >>>
'"/>

Source:wistechnology.com By Tom Still 09/12/05


Related biology technology :

1. National angel investment grew 11 percent in `06
2. Musicnotes reports 45 percent growth in 2006
3. Fiserv posts 30 percent quarterly loss
4. RedPrairie exec calls for 50 percent tax cut
5. Renaissance earnings down 46 percent
6. GE Healthcare third-quarter profits up 17 percent
7. Criticare reports 20.3 percent increase in sales
8. Rockwell Automation ups quarterly dividend by 36 percent
9. Its 99 percent certain: Research cannot rely on adult stem cells alone
10. A disgusting video: U.S. companies sell out Americans
11. Pre-eminent, web-based companies owe success to corporate venturing
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):